These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 29324897

  • 1. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.
    PLoS One; 2018; 13(1):e0190967. PubMed ID: 29324897
    [Abstract] [Full Text] [Related]

  • 2. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J.
    J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
    [Abstract] [Full Text] [Related]

  • 3. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    Maixnerova D, Ling C, Hall S, Reily C, Brown R, Neprasova M, Suchanek M, Honsova E, Zima T, Novak J, Tesar V.
    PLoS One; 2019 Mar; 14(2):e0212254. PubMed ID: 30794576
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
    Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J.
    J Am Soc Nephrol; 2012 Sep; 23(9):1579-87. PubMed ID: 22904352
    [Abstract] [Full Text] [Related]

  • 5. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
    Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y.
    PLoS One; 2014 Sep; 9(5):e98081. PubMed ID: 24858067
    [Abstract] [Full Text] [Related]

  • 6. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 7. Biomarkers in IgA nephropathy: relationship to pathogenetic hits.
    Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J, Wyatt RJ.
    Expert Opin Med Diagn; 2013 Nov; 7(6):615-27. PubMed ID: 24175678
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z, Zhang X, Han W, Yu G, Ying Z, Xu X, Wang M, Zhou X, Lv J, Zhang H.
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
    Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J.
    PLoS One; 2016 Feb; 11(12):e0166830. PubMed ID: 27930655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
    Berthoux F, Suzuki H, Mohey H, Maillard N, Mariat C, Novak J, Julian BA.
    J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
    [Abstract] [Full Text] [Related]

  • 14. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 16. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020 Jun 07; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 17. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Jun 07; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 18. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 07; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 19. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Fatima H, Julian BA, Novak J.
    J Am Soc Nephrol; 2019 Oct 07; 30(10):2017-2026. PubMed ID: 31444275
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.
    Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.
    Pediatr Nephrol; 2007 Dec 07; 22(12):2067-72. PubMed ID: 17943324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.